Acceptance and Hesitancy of Covid-19 Vaccine among Pregnant Women Attending Antenatal Care Clinic at Makongoro Hospital, Mwanza-Tanzania. (Record no. 23015)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03490nam a22003137a 4500 |
| 001 - CONTROL NUMBER | |
| control field | CUHAS/MD/4002581/T/18 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | CUHAS/MD/4002581/T/18 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240305194009.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 231103b |||||||| |||| 00| 0 eng d |
| 028 ## - PUBLISHER OR DISTRIBUTOR NUMBER | |
| Source | Phone: +255 28 298 3384 |
| Source | Fax: +255 28 298 3386 |
| Source | Email: vc@bugando.ac.tz |
| Source | Website: www.bugando.ac.tz |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | CUHAS/MD/4002581/T/18 |
| 040 ## - CATALOGING SOURCE | |
| Language of cataloging | English |
| Transcribing agency | DDC |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| Language code of text/sound track or separate title | Kiswahili |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Kevin John Zangira |
| Dates associated with a name | CUHAS/MD/4002581/T/18 |
| 245 ## - TITLE STATEMENT | |
| Title | Acceptance and Hesitancy of Covid-19 Vaccine among Pregnant Women Attending Antenatal Care Clinic at Makongoro Hospital, Mwanza-Tanzania. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Mwanza, Tanzania: |
| Name of publisher, distributor, etc. | Catholic University of Health and Allied Sciences [CUHAS – Bugando] : |
| Date of publication, distribution, etc. | ©2023 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 52 Pages |
| Extent | Includes References and Appendicies |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Abstract: <br/> <br/>Introduction and Problem Statement: Corona virus diseases 2019 (COVID-19) is a respiratory tract infection that is caused by a novel coronavirus (SARS-CoV-2) that emerged in December 2019 in Wuhan, China. Pregnant women had an increased risk of developing worse pregnancy outcomes like preeclampsia, preterm delivery, gestational diabetes and low birth weight in pregnancy (1). The main reasons for very low vaccine acceptance are the fear of side effects and lack of confidence in vaccine effectiveness. <br/><br/>Objective: Assessing the acceptance and hesitancy level of COVID-19 vaccine among pregnant women attending ANC Clinic at Makongoro Hospital, Mwanza-Tanzania.<br/><br/>METHODS: A hospital-based cross-sectional was conducted among 321 pregnant women attending ANC at Makongoro Hospital who voluntarily consented to participate in the study. <br/><br/>Results: All participants have ever been vaccinated before in life aside from the COVID-19 vaccine and among them only 11.2% got complications after the vaccination. Among all participants, only 32.7% received a COVID-19 vaccine and 42.1% of all participants believe that COVID-19 vaccines could harm them and their babies. 62.6% of all participants believed that vaccines are important for their health and 52.3% believed that COVID-19 vaccines are effective while 29% believed that new vaccines including COVID-19 vaccines carried more risks than older vaccines. 77.9% of the participants were concerned about serious adverse effects of vaccines.<br/><br/>Conclusion: Participants in their first trimester expressed greater interest in receiving the COVID-19 vaccination compared with participants in their second and third trimesters (p<0.05) in which the results were consistent with the results of the study conducted by Sule Goncu et al (2). The greatest concern about the COVID-19 vaccine among the hesitant pregnant women was a lack of data about safety in the pregnant population consistent with the study conducted in the United States in December 2020 by Sara E. Oliver et al(3). The main barriers that contributed to vaccine hesitancy in this study were the fear of the safety and side effects of the vaccine, its effectiveness and the fast pace of the vaccine’s development, as compared to other common vaccines, this is consistent with the study conducted in 2021 by Fidelia Cascini et al (4).<br/> <br/> |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Biostatistics and Epidemiology |
| General subdivision | Pharmacology |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | UNDERGRADUATE DISSERTATIONS |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Date acquired | Total checkouts | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 11/03/2023 | CUHAS/MD/4002581/T/1 | 11/03/2023 | 11/03/2023 | UNDERGRADUATE DISSERTATIONS |